MEDEVAL

Active

Private limited companyfounded 1999active for 26 yearsWaterloosesteenweg 1329A, 1180 Ukkel, BelgiumKBO/BCE: BE 0468.961.445

Summary

MEDEVAL has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €911,115 and a net result of €127,349. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 73% of 3,001 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

MEDEVALActiveChecked score 94/100

Risk analysis Report Compare

Register details

Identification

Legal formPrivate limited company

Founded29-12-1999

Financial year end31-12

Activities, NACEBEL 2025

86220Specialist medical practice

E-invoicing

Reachable via Peppol

Peppol ID 0208:0468961445

Also 9925:BE0468961445

Registered 24-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint

Registered office, Ukkel · 1 establishment unit since 2000

registered office establishment approximate The establishment unit on the map

Ground area

7.3 ha

Building footprint

5,010 m²

Building volume

54,099 m³

2 parcels, Brussels · tallest building 21.7 m. Linked by address, not a title deed.

3 companies at this address See who is registered here

1 establishment unit

Waterloosesteenweg 1329, 1180 Ukkel

Specialist medical practice

since 2000unit no. 2.231.323.464

2 parcels

Brussels 2 (100%)

Cadastral parcel	Region	Area	Buildings	Height / floors
21612C0293/00S002	Brussels	6.8 ha	1 · 3,854 m²	18.2 m · 3
21614H0003/00N007	Brussels	5,665 m²	1 · 1,156 m²	21.7 m · 6

How the parcels are linked

Good to know

Both parcels match the address exactly.